Bausch Health Companies Stock Performance
BHC Stock | USD 10.49 0.63 6.39% |
On a scale of 0 to 100, Bausch Health holds a performance score of 15. The firm shows a Beta (market volatility) of 1.91, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bausch Health will likely underperform. Please check Bausch Health's sortino ratio, potential upside, skewness, as well as the relationship between the maximum drawdown and semi variance , to make a quick decision on whether Bausch Health's price patterns will revert.
Risk-Adjusted Performance
15 of 100
Low | High |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bausch Health Companies are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical indicators, Bausch Health exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 6.39 | Five Day Return 11.24 | Year To Date Return 34.83 | Ten Year Return (91.78) | All Time Return 2 K |
Last Split Factor 2:1 | Ex Dividend Date 2010-11-10 | Last Split Date 2000-10-16 |
1 | Acquisition by Amy Wechsler of 857 shares of Bausch Health subject to Rule 16b-3 | 01/02/2024 |
2 | StockNews.com Upgrades Bausch Health Companies to Buy | 01/25/2024 |
3 | Will Bausch Beat Estimates Again in Its Next Earnings Report | 02/21/2024 |
4 | Looking At Bausch Health Companiess Recent Unusual Options Activity | 02/22/2024 |
5 | Bausch Health Companies Inc. Q4 2023 Earnings Call Transcript | 02/23/2024 |
6 | Nomura Holdings Inc. Has 148.67 Million Stock Position in Bausch Health Companies Inc. | 02/27/2024 |
7 | Q4 2023 Bausch Health Companies Inc Earnings Call Transcript | 02/28/2024 |
8 | Acquisition by Seana Carson of 147536 shares of Bausch Health subject to Rule 16b-3 | 02/29/2024 |
9 | February was a great month for Wall Street. These were our 5 best-performing stocks | 03/01/2024 |
10 | Disposition of 133 shares by Seana Carson of Bausch Health at 9.8 subject to Rule 16b-3 | 03/04/2024 |
11 | Why Bausch Health is a Top Momentum Stock for the Long-Term | 03/15/2024 |
12 | Canopus Biopharma Inc. dba Blue Heaven Coffee Inc. Announces and Secures New Unattended Retail Management Platform - Parlevel systems | 03/19/2024 |
Begin Period Cash Flow | 591 M |
Bausch |
Bausch Health Relative Risk vs. Return Landscape
If you would invest 802.00 in Bausch Health Companies on December 29, 2023 and sell it today you would earn a total of 247.00 from holding Bausch Health Companies or generate 30.8% return on investment over 90 days. Bausch Health Companies is generating 0.4661% of daily returns assuming volatility of 2.2701% on return distribution over 90 days investment horizon. In other words, 20% of stocks are less volatile than Bausch, and above 91% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
Risk |
Bausch Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bausch Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bausch Health Companies, and traders can use it to determine the average amount a Bausch Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2053
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | BHC | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.27 actual daily | 20 80% of assets are more volatile |
Expected Return
0.47 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
0.21 actual daily | 15 85% of assets perform better |
Based on monthly moving average Bausch Health is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bausch Health by adding it to a well-diversified portfolio.
Bausch Health Fundamentals Growth
Bausch Stock prices reflect investors' perceptions of the future prospects and financial health of Bausch Health, and Bausch Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bausch Stock performance.
Return On Equity | -6.87 | ||||
Return On Asset | 0.0382 | ||||
Current Valuation | 25.04 B | ||||
Shares Outstanding | 365.41 M | ||||
Price To Earning | 9.26 X | ||||
Price To Book | 18.78 X | ||||
Price To Sales | 0.41 X | ||||
Revenue | 8.76 B | ||||
Gross Profit | 5.76 B | ||||
EBITDA | 2.89 B | ||||
Net Income | (611 M) | ||||
Cash And Equivalents | 564 M | ||||
Cash Per Share | 1.34 X | ||||
Current Ratio | 1.05 X | ||||
Cash Flow From Operations | 1.03 B | ||||
Earnings Per Share | (1.62) X | ||||
Total Asset | 27.35 B | ||||
Retained Earnings | (9.78 B) | ||||
Current Asset | 984.02 M | ||||
About Bausch Health Performance
To evaluate Bausch Health Companies Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Bausch Health generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Bausch Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Bausch Health Companies market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Bausch's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for 2024 | ||
Return On Capital Employed | 0.04 | 0.04 | |
Return On Assets | (0.02) | (0.02) | |
Return On Equity | 0.58 | 0.61 |
Things to note about Bausch Health Companies performance evaluation
Checking the ongoing alerts about Bausch Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bausch Health Companies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.The company reported the last year's revenue of 8.76 B. Reported Net Loss for the year was (611 M) with profit before taxes, overhead, and interest of 5.76 B. | |
Bausch Health has a strong financial position based on the latest SEC filings | |
Over 81.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from finance.yahoo.com: Canopus Biopharma Inc. dba Blue Heaven Coffee Inc. Announces and Secures New Unattended Retail Management Platform - Parlevel systems |
- Analyzing Bausch Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bausch Health's stock is overvalued or undervalued compared to its peers.
- Examining Bausch Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bausch Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bausch Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bausch Health's stock. These opinions can provide insight into Bausch Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Bausch Health Companies information on this page should be used as a complementary analysis to other Bausch Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Bausch Stock analysis
When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is Bausch Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.115 | Earnings Share (1.62) | Revenue Per Share 23.998 | Quarterly Revenue Growth 0.098 | Return On Assets 0.0382 |
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.